Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts

Liposomal siRNA nanocarriers for cancer therapy

(2014) Bulent Ozpolat et al.   ADVANCED DRUG DELIVERY REVIEWS

Structure and kinetics of lipid–nucleic acid complexes

(2014) Nily Dan et al.   ADVANCES IN COLLOID AND INTERFACE SCIENCE

Multifunctional RNA Nanoparticles

(2014) Kirill A. Afonin et al.   NANO LETTERS

The Headgroup Evolution of Cationic Lipids for Gene Delivery

(2013) Defu Zhi et al.   BIOCONJUGATE CHEMISTRY

Mechanism of Membrane Permeation Induced by Synthetic β-Hairpin Peptides

(2013) Kshitij Gupta et al.   BIOPHYSICAL JOURNAL

Delivery materials for siRNA therapeutics

(2013) Rosemary Kanasty et al.   NATURE MATERIALS

Cationic lipophosphoramidates with two different lipid chains: synthesis and evaluation as gene carriers

(2013) Stéphanie S. Le Corre et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

In Silico, In Vitro, and In Vivo Studies Indicate the Potential Use of Bolaamphiphiles for Therapeutic siRNAs Delivery

(2013) Taejin Kim et al.   Molecular Therapy-Nucleic Acids

Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells

(2012) Tatiana I Novobrantseva et al.   Molecular Therapy-Nucleic Acids

Lipophosphonate/lipophosphoramidates: A family of synthetic vectors efficient for gene delivery

(2011) Mathieu Berchel et al.   BIOCHIMIE

Hydrophobic Oxime Ethers: A Versatile Class of pDNA and siRNA Transfection Lipids

(2011) Souvik Biswas et al.   ChemMedChem

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine

(2011) Kirill A Afonin et al.   Nature Protocols

The Benefit of Hydrophobic Domain Asymmetry on the Efficacy of Transfection as Measured byin VivoImaging

(2010) Michael H. Nantz et al.   MOLECULAR PHARMACEUTICS

Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

(2010) Akin Akinc et al.   MOLECULAR THERAPY

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

(2010) Mark E. Davis et al.   NATURE

Nucleophilic cationization reagents

(2010) Souvik Biswas et al.   TETRAHEDRON LETTERS

RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

(2009) R. Alvarez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Controlling HBV Replicationin Vivoby Intravenous Administration of Triggered PEGylated siRNA-Nanoparticles

(2009) Sergio Carmona et al.   MOLECULAR PHARMACEUTICS

Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver

(2009) Akin Akinc et al.   MOLECULAR THERAPY

Structure–Function Relationship Research of Glycerol Backbone-Based Cationic Lipids for Gene Delivery

(2008) Dongliang Liu et al.   Chemical Biology & Drug Design

Direct CNS Delivery of siRNA Mediates Robust Silencing in Oligodendrocytes

(2008) William Querbes et al.   OLIGONUCLEOTIDES